Industry Research Reports

Home > Reports > Service & Software > Global Innovative Drug CDMO Market Research Report 2024

Global Innovative Drug CDMO Market Research Report 2024

Industry: Service & Software

Published Date: 2024-04-28

Pages: 78 Pages

Report ld: 3133156

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Innovative Drug CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Innovative Drug CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Innovative Drug CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Innovative Drug CDMO in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Innovative Drug CDMO include Skyepharma, Asymchem, Recipharm, CoreRx, Pierre Fabre, CentreOne, Axplora, Kindeva, Quotient Sciences, Lonza, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Innovative Drug CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Innovative Drug CDMO.

The Innovative Drug CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Innovative Drug CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Innovative Drug CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Skyepharma
Asymchem
Recipharm
CoreRx
Pierre Fabre
CentreOne
Axplora
Kindeva
Quotient Sciences
Lonza

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Small Molecule CDMO
Macromolecule CDMO
Cell Gene Therapy (CGT) CDMO

Segment by Application

Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Innovative Drug CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Innovative Drug CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Small Molecule CDMO

1.2.3 Macromolecule CDMO

1.2.4 Cell Gene Therapy (CGT) CDMO

1.3 Market by Application

1.3.1 Global Innovative Drug CDMO Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research and Academic Institutions

1.3.4 Hospital

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Innovative Drug CDMO Market Perspective (2019-2030)

2.2 Global Innovative Drug CDMO Growth Trends by Region

2.2.1 Global Innovative Drug CDMO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Innovative Drug CDMO Historic Market Size by Region (2019-2024)

2.2.3 Innovative Drug CDMO Forecasted Market Size by Region (2025-2030)

2.3 Innovative Drug CDMO Market Dynamics

2.3.1 Innovative Drug CDMO Industry Trends

2.3.2 Innovative Drug CDMO Market Drivers

2.3.3 Innovative Drug CDMO Market Challenges

2.3.4 Innovative Drug CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Innovative Drug CDMO Players by Revenue

3.1.1 Global Top Innovative Drug CDMO Players by Revenue (2019-2024)

3.1.2 Global Innovative Drug CDMO Revenue Market Share by Players (2019-2024)

3.2 Global Innovative Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Innovative Drug CDMO Revenue

3.4 Global Innovative Drug CDMO Market Concentration Ratio

3.4.1 Global Innovative Drug CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Innovative Drug CDMO Revenue in 2023

3.5 Global Key Players of Innovative Drug CDMO Head office and Area Served

3.6 Global Key Players of Innovative Drug CDMO, Product and Application

3.7 Global Key Players of Innovative Drug CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Innovative Drug CDMO Breakdown Data by Type

4.1 Global Innovative Drug CDMO Historic Market Size by Type (2019-2024)

4.2 Global Innovative Drug CDMO Forecasted Market Size by Type (2025-2030)

5 Innovative Drug CDMO Breakdown Data by Application

5.1 Global Innovative Drug CDMO Historic Market Size by Application (2019-2024)

5.2 Global Innovative Drug CDMO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Innovative Drug CDMO Market Size (2019-2030)

6.2 North America Innovative Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Innovative Drug CDMO Market Size by Country (2019-2024)

6.4 North America Innovative Drug CDMO Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Innovative Drug CDMO Market Size (2019-2030)

7.2 Europe Innovative Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Innovative Drug CDMO Market Size by Country (2019-2024)

7.4 Europe Innovative Drug CDMO Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Innovative Drug CDMO Market Size (2019-2030)

8.2 Asia-Pacific Innovative Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Innovative Drug CDMO Market Size by Region (2019-2024)

8.4 Asia-Pacific Innovative Drug CDMO Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Innovative Drug CDMO Market Size (2019-2030)

9.2 Latin America Innovative Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Innovative Drug CDMO Market Size by Country (2019-2024)

9.4 Latin America Innovative Drug CDMO Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Innovative Drug CDMO Market Size (2019-2030)

10.2 Middle East & Africa Innovative Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Innovative Drug CDMO Market Size by Country (2019-2024)

10.4 Middle East & Africa Innovative Drug CDMO Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Skyepharma

11.1.1 Skyepharma Company Details

11.1.2 Skyepharma Business Overview

11.1.3 Skyepharma Innovative Drug CDMO Introduction

11.1.4 Skyepharma Revenue in Innovative Drug CDMO Business (2019-2024)

11.1.5 Skyepharma Recent Development

11.2 Asymchem

11.2.1 Asymchem Company Details

11.2.2 Asymchem Business Overview

11.2.3 Asymchem Innovative Drug CDMO Introduction

11.2.4 Asymchem Revenue in Innovative Drug CDMO Business (2019-2024)

11.2.5 Asymchem Recent Development

11.3 Recipharm

11.3.1 Recipharm Company Details

11.3.2 Recipharm Business Overview

11.3.3 Recipharm Innovative Drug CDMO Introduction

11.3.4 Recipharm Revenue in Innovative Drug CDMO Business (2019-2024)

11.3.5 Recipharm Recent Development

11.4 CoreRx

11.4.1 CoreRx Company Details

11.4.2 CoreRx Business Overview

11.4.3 CoreRx Innovative Drug CDMO Introduction

11.4.4 CoreRx Revenue in Innovative Drug CDMO Business (2019-2024)

11.4.5 CoreRx Recent Development

11.5 Pierre Fabre

11.5.1 Pierre Fabre Company Details

11.5.2 Pierre Fabre Business Overview

11.5.3 Pierre Fabre Innovative Drug CDMO Introduction

11.5.4 Pierre Fabre Revenue in Innovative Drug CDMO Business (2019-2024)

11.5.5 Pierre Fabre Recent Development

11.6 CentreOne

11.6.1 CentreOne Company Details

11.6.2 CentreOne Business Overview

11.6.3 CentreOne Innovative Drug CDMO Introduction

11.6.4 CentreOne Revenue in Innovative Drug CDMO Business (2019-2024)

11.6.5 CentreOne Recent Development

11.7 Axplora

11.7.1 Axplora Company Details

11.7.2 Axplora Business Overview

11.7.3 Axplora Innovative Drug CDMO Introduction

11.7.4 Axplora Revenue in Innovative Drug CDMO Business (2019-2024)

11.7.5 Axplora Recent Development

11.8 Kindeva

11.8.1 Kindeva Company Details

11.8.2 Kindeva Business Overview

11.8.3 Kindeva Innovative Drug CDMO Introduction

11.8.4 Kindeva Revenue in Innovative Drug CDMO Business (2019-2024)

11.8.5 Kindeva Recent Development

11.9 Quotient Sciences

11.9.1 Quotient Sciences Company Details

11.9.2 Quotient Sciences Business Overview

11.9.3 Quotient Sciences Innovative Drug CDMO Introduction

11.9.4 Quotient Sciences Revenue in Innovative Drug CDMO Business (2019-2024)

11.9.5 Quotient Sciences Recent Development

11.10 Lonza

11.10.1 Lonza Company Details

11.10.2 Lonza Business Overview

11.10.3 Lonza Innovative Drug CDMO Introduction

11.10.4 Lonza Revenue in Innovative Drug CDMO Business (2019-2024)

11.10.5 Lonza Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Innovative Drug CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Small Molecule CDMO

Table 3. Key Players of Macromolecule CDMO

Table 4. Key Players of Cell Gene Therapy (CGT) CDMO

Table 5. Global Innovative Drug CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Innovative Drug CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Innovative Drug CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Innovative Drug CDMO Market Share by Region (2019-2024)

Table 9. Global Innovative Drug CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Innovative Drug CDMO Market Share by Region (2025-2030)

Table 11. Innovative Drug CDMO Market Trends

Table 12. Innovative Drug CDMO Market Drivers

Table 13. Innovative Drug CDMO Market Challenges

Table 14. Innovative Drug CDMO Market Restraints

Table 15. Global Innovative Drug CDMO Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Innovative Drug CDMO Market Share by Players (2019-2024)

Table 17. Global Top Innovative Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug CDMO as of 2023)

Table 18. Ranking of Global Top Innovative Drug CDMO Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Innovative Drug CDMO Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Innovative Drug CDMO, Headquarters and Area Served

Table 21. Global Key Players of Innovative Drug CDMO, Product and Application

Table 22. Global Key Players of Innovative Drug CDMO, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Innovative Drug CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Innovative Drug CDMO Revenue Market Share by Type (2019-2024)

Table 26. Global Innovative Drug CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Innovative Drug CDMO Revenue Market Share by Type (2025-2030)

Table 28. Global Innovative Drug CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Innovative Drug CDMO Revenue Market Share by Application (2019-2024)

Table 30. Global Innovative Drug CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Innovative Drug CDMO Revenue Market Share by Application (2025-2030)

Table 32. North America Innovative Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Innovative Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Innovative Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Innovative Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Innovative Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Innovative Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Innovative Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Innovative Drug CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Innovative Drug CDMO Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Innovative Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Innovative Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Innovative Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Innovative Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Innovative Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Innovative Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 47. Skyepharma Company Details

Table 48. Skyepharma Business Overview

Table 49. Skyepharma Innovative Drug CDMO Product

Table 50. Skyepharma Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 51. Skyepharma Recent Development

Table 52. Asymchem Company Details

Table 53. Asymchem Business Overview

Table 54. Asymchem Innovative Drug CDMO Product

Table 55. Asymchem Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 56. Asymchem Recent Development

Table 57. Recipharm Company Details

Table 58. Recipharm Business Overview

Table 59. Recipharm Innovative Drug CDMO Product

Table 60. Recipharm Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 61. Recipharm Recent Development

Table 62. CoreRx Company Details

Table 63. CoreRx Business Overview

Table 64. CoreRx Innovative Drug CDMO Product

Table 65. CoreRx Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 66. CoreRx Recent Development

Table 67. Pierre Fabre Company Details

Table 68. Pierre Fabre Business Overview

Table 69. Pierre Fabre Innovative Drug CDMO Product

Table 70. Pierre Fabre Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 71. Pierre Fabre Recent Development

Table 72. CentreOne Company Details

Table 73. CentreOne Business Overview

Table 74. CentreOne Innovative Drug CDMO Product

Table 75. CentreOne Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 76. CentreOne Recent Development

Table 77. Axplora Company Details

Table 78. Axplora Business Overview

Table 79. Axplora Innovative Drug CDMO Product

Table 80. Axplora Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 81. Axplora Recent Development

Table 82. Kindeva Company Details

Table 83. Kindeva Business Overview

Table 84. Kindeva Innovative Drug CDMO Product

Table 85. Kindeva Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 86. Kindeva Recent Development

Table 87. Quotient Sciences Company Details

Table 88. Quotient Sciences Business Overview

Table 89. Quotient Sciences Innovative Drug CDMO Product

Table 90. Quotient Sciences Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 91. Quotient Sciences Recent Development

Table 92. Lonza Company Details

Table 93. Lonza Business Overview

Table 94. Lonza Innovative Drug CDMO Product

Table 95. Lonza Revenue in Innovative Drug CDMO Business (2019-2024) & (US$ Million)

Table 96. Lonza Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Innovative Drug CDMO Picture

Figure 2. Global Innovative Drug CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Innovative Drug CDMO Market Share by Type: 2023 VS 2030

Figure 4. Small Molecule CDMO Features

Figure 5. Macromolecule CDMO Features

Figure 6. Cell Gene Therapy (CGT) CDMO Features

Figure 7. Global Innovative Drug CDMO Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Innovative Drug CDMO Market Share by Application: 2023 VS 2030

Figure 9. Pharmaceutical and Biotechnology Companies Case Studies

Figure 10. Research and Academic Institutions Case Studies

Figure 11. Hospital Case Studies

Figure 12. Others Case Studies

Figure 13. Innovative Drug CDMO Report Years Considered

Figure 14. Global Innovative Drug CDMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Innovative Drug CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Innovative Drug CDMO Market Share by Region: 2023 VS 2030

Figure 17. Global Innovative Drug CDMO Market Share by Players in 2023

Figure 18. Global Top Innovative Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug CDMO as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Innovative Drug CDMO Revenue in 2023

Figure 20. North America Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Innovative Drug CDMO Market Share by Country (2019-2030)

Figure 22. United States Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Innovative Drug CDMO Market Share by Country (2019-2030)

Figure 26. Germany Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Innovative Drug CDMO Market Share by Region (2019-2030)

Figure 34. China Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Innovative Drug CDMO Market Share by Country (2019-2030)

Figure 42. Mexico Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Innovative Drug CDMO Market Share by Country (2019-2030)

Figure 46. Turkey Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Innovative Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Skyepharma Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 50. Asymchem Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 51. Recipharm Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 52. CoreRx Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 53. Pierre Fabre Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 54. CentreOne Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 55. Axplora Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 56. Kindeva Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 57. Quotient Sciences Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 58. Lonza Revenue Growth Rate in Innovative Drug CDMO Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Innovative Drug CDMO market? zhanKai

The top companies in the global Innovative Drug CDMO market are Skyepharma、Asymchem、Recipharm.

Related Reports

Global Innovative Drug CDMO Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Innovative Drug CDMO market is projected to grow from US$ 2930 million in 2025 to US$ 5139 million by 2032, at a CAGR of 8.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 139
USD 4900.00
(Single User License)
Global Innovative Drug CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Innovative Drug CDMO market size was US$ 2930 million in 2025 and is forecast to reach a readjusted size of US$ 5139 million by 2032 with a CAGR of 8.5% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 97
USD 4250.00
(Single User License)
Innovative Drug CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Innovative Drug CDMO was estimated to be worth US$ 2930 million in 2025 and is projected to reach US$ 5139 million, growing at a CAGR of 8.5% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 111
USD 3950.00
(Single User License)
Global Innovative Drug CDMO Market Research Report 2026
The global Innovative Drug CDMO market was valued at US$ 2930 million in 2025 and is anticipated to reach US$ 5139 million by 2032, at a CAGR of 8.5% from 2026 to 2032.
Published Date: 2026-01-15
Pages: 119
USD 2900.00
(Single User License)
Innovative Drug CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Innovative Drug CDMO was estimated to be worth US$ 2710 million in 2024 and is forecast to a readjusted size of US$ 4775 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 120
USD 3950.00
(Single User License)
Global Innovative Drug CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Innovative Drug CDMO market size was US$ 2710 million in 2024 and is forecast to a readjusted size of US$ 4775 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 93
USD 4250.00
(Single User License)
Global Innovative Drug CDMO Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Innovative Drug CDMO market is projected to grow from US$ 2710 million in 2024 to US$ 4775 million by 2031, at a CAGR of 8.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-12-12
Pages: 139
USD 4900.00
(Single User License)
Global Innovative Drug CDMO Market Research Report 2025
The global market for Innovative Drug CDMO was valued at US$ 2710 million in the year 2024 and is projected to reach a revised size of US$ 4775 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Published Date: 2025-12-12
Pages: 113
USD 2900.00
(Single User License)
Innovative Drug CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Innovative Drug CDMO was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 88
USD 3950.00
(Single User License)
Innovative Drug CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Innovative Drug CDMO was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-04-28
Pages: 98
USD 3950.00
(Single User License)

Global Innovative Drug CDMO Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Innovative Drug CDMO market is projected to grow from US$ 2930 million in 2025 to US$ 5139 million by 2032, at a CAGR of 8.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 139
USD 4900.00 (Single User License)
Global Innovative Drug CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Innovative Drug CDMO market size was US$ 2930 million in 2025 and is forecast to reach a readjusted size of US$ 5139 million by 2032 with a CAGR of 8.5% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 97
USD 4250.00 (Single User License)
Innovative Drug CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Innovative Drug CDMO was estimated to be worth US$ 2930 million in 2025 and is projected to reach US$ 5139 million, growing at a CAGR of 8.5% from 2026 to 2032.
Published: 2026-01-19
Pages: 111
USD 3950.00 (Single User License)
Global Innovative Drug CDMO Market Research Report 2026
The global Innovative Drug CDMO market was valued at US$ 2930 million in 2025 and is anticipated to reach US$ 5139 million by 2032, at a CAGR of 8.5% from 2026 to 2032.
Published: 2026-01-15
Pages: 119
USD 2900.00 (Single User License)
Innovative Drug CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Innovative Drug CDMO was estimated to be worth US$ 2710 million in 2024 and is forecast to a readjusted size of US$ 4775 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 120
USD 3950.00 (Single User License)
Global Innovative Drug CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Innovative Drug CDMO market size was US$ 2710 million in 2024 and is forecast to a readjusted size of US$ 4775 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 93
USD 4250.00 (Single User License)
Global Innovative Drug CDMO Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Innovative Drug CDMO market is projected to grow from US$ 2710 million in 2024 to US$ 4775 million by 2031, at a CAGR of 8.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 139
USD 4900.00 (Single User License)
Global Innovative Drug CDMO Market Research Report 2025
The global market for Innovative Drug CDMO was valued at US$ 2710 million in the year 2024 and is projected to reach a revised size of US$ 4775 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Published: 2025-12-12
Pages: 113
USD 2900.00 (Single User License)
Innovative Drug CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Innovative Drug CDMO was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 88
USD 3950.00 (Single User License)
Innovative Drug CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Innovative Drug CDMO was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 98
USD 3950.00 (Single User License)